Question 1

What is the catalog number for Compound STOCK1N-92957?

Accepted Answer

The catalog number for Compound STOCK1N-92957 is T126678.

Question 2

Is Compound STOCK1N-92957 in stock?

Accepted Answer

Compound STOCK1N-92957 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound STOCK1N-92957?

Accepted Answer

Compound STOCK1N-92957 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound STOCK1N-92957?

Accepted Answer

Estimated delivery time for Compound STOCK1N-92957 is approximately 10 business day(s), depending on your location.

Question 5

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 6

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 7

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Compound STOCK1N-92957

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Ɑ-Methoxy-ω-Succinamic Acid NHS Ester PEG

Terfuboxon

TAFA5 (NM_015381) Human Over-expression Lysate

Thyroid Stimulating Hormone, beta (TSH beta) (Pituitary Marker) (TSHb/1317), CF568 conjugate, 0.1mg/mL

Butamirate

Human Ramp4 2 (SERP2) activation kit by CRISPRa